The ROE as of December 2024 (TTM) for Processa Pharmaceuticals, Inc. (PCSA) is -195.22%

According to Processa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -195.22%. This represents a change of 255.21% compared to the average of -54.96% of the last 4 quarters.

Processa Pharmaceuticals, Inc. (PCSA) Historical ROE (quarterly & annually)

How has PCSA ROE performed in the past?

The mean historical ROE of Processa Pharmaceuticals, Inc. over the last ten years is -183.38%. The current -195.22% ROE has changed 6.45% with respect to the historical average. Over the past ten years (40 quarters), PCSA's ROE was at its highest in in the September 2017 quarter at 583.17%. The ROE was at its lowest in in the December 2022 quarter at -460.68%.

Processa Pharmaceuticals, Inc. (PCSA) ROE by Quarter and Year

Discovering the peaks and valleys of Processa Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Processa Pharmaceuticals, Inc. (PCSA) Average ROE

How has PCSA ROE performed in the past?

The current ROE of Processa Pharmaceuticals, Inc. (PCSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Processa Pharmaceuticals, Inc. (PCSA) ROE vs. Peers

How is PCSA’s ROE compared to its peers?

Processa Pharmaceuticals, Inc.’s ROE is less than Alpha Cognition Inc. (666.93%), greater than Eupraxia Pharmaceuticals Inc. (-182.55%), greater than Acurx Pharmaceuticals, Inc. (-67679.28%), less than Fennec Pharmaceuticals Inc. (31.99%), less than Comera Life Sciences Holdings, Inc. (67.46%), greater than SAB Biotherapeutics, Inc. (-94.37%), greater than Fresh Tracks Therapeutics, Inc. (-14.73%), greater than Third Harmonic Bio, Inc. (-14.46%), less than Eliem Therapeutics, Inc. (0%), less than Inhibrx Biosciences, Inc. (1.45%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%), greater than Celcuity Inc. (-62.66%), greater than Enliven Therapeutics, Inc. (-29.46%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Miromatrix Medical Inc. (-70.01%), greater than Inhibikase Therapeutics, Inc. (-350.62%), greater than PMV Pharmaceuticals, Inc. (-24.20%), greater than Anebulo Pharmaceuticals, Inc. (-184.40%), less than Akari Therapeutics, Plc (550.78%), less than Armata Pharmaceuticals, Inc. (89.12%), less than Scopus BioPharma Inc. (911.69%),

Build a custom stock screener for Processa Pharmaceuticals, Inc. (PCSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Processa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Processa Pharmaceuticals, Inc. (PCSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Processa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.